The Beneficial Effects of Lactobacillus GG Therapy on Liver and Drinking Assessments in Patients with Moderate Alcohol-Associated Hepatitis

Vatsalya Vatsalya, Wenke Feng, Maiying Kong, Huirong Hu, Gyongyi Szabo, Arthur McCullough, Srinivasan Dasarathy, Laura E. Nagy, Svetlana Radaeva, Bruce Barton, Mack Mitchell, Craig J. McClain

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

INTRODUCTION:We investigated the effect of daily oral Lactobacillus rhamnosus GG (LGG) in reducing liver injury/severity and drinking in patients with alcohol use disorder and moderately severe alcohol-associated hepatitis.METHODS:Forty-six male and female individuals with alcohol use disorder and moderate alcohol-associated hepatitis (12 ≤ model for end-stage liver disease score < 20, aged 21-67 years) received either LGG (n = 24) or placebo (n = 22). Data were collected/assessed at baseline and at 1, 3, and 6 months.RESULTS:LGG treatment was associated with a significant reduction in liver injury after 1 month. Six months of LGG treatment reduced heavy drinking levels to social or abstinence levels.DISCUSSION:LGG treatment was associated with an improvement in both liver injury and drinking.

Original languageEnglish (US)
Pages (from-to)1457-1460
Number of pages4
JournalAmerican Journal of Gastroenterology
Volume118
Issue number8
DOIs
StatePublished - Aug 1 2023

Keywords

  • alcohol intake
  • alcohol-associated hepatitis
  • lactobacillus GG
  • liver injury
  • probiotic

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint

Dive into the research topics of 'The Beneficial Effects of Lactobacillus GG Therapy on Liver and Drinking Assessments in Patients with Moderate Alcohol-Associated Hepatitis'. Together they form a unique fingerprint.

Cite this